1/18
Looks like no tags are added yet.
Desmopressin
Used in mild hemophilia A + von Willebrand disease (type 1)
MOA:
Stimulates V2 receptors —> triggers release of vWF and factor VIII —> increases clot formation
ADR:
hyponatremia: monitor sodium!!
*pt can not take with aspirin
*limit free water
Tranexamic Acid (TXA)
Used for bleedingafter trauma, surgery, postpartum hemorrhage
MOA:
blocks plasminogen binding to fibrin —> prevents dissolution of clot
ADR:
seizures
hypotension
*monitor for DVT/PE
Aminocaproic Acid
Antifibrinolytic
Used for hemophilia-related bleeding, surgical bleeding
MOA:
inhibits plasminogen activation —> decreases plasmin —> decreases fibrin breakdown
ADR:
hypotension (administer slowly via IV!!)
*monitor for DVT/PE
Hemostatic Agent Therapy Overview
DDAVP (desmopressin) promotes clot formation
Antifibrinolytics prevent clot breakdown
Antithrombotic Therapy Overview
Prevent or treat harmful blood clot formation
antiplatelets
anticoagulants
thrombolytics
* Nobody on anticoagulants can take NSAIDs
Cox-1 Inhibitors Prototype
Aspirin
Aspirin
MOA:
Inhibits COX-1 —> lowers platelet activation and aggregation
wors on intrinsic pathways
ADR:
bleeding
*do not give to children under 18 w/ viral illness = Reye’s syndrome
P2Y12 receptor inhibitors prototype
clopidogrel
often used with aspirin
Clopidogrel
MOA:
blocks P2Y12 receptors —> lowers platelet activation and aggregation
ADR:
bleeding/ hemorrhage
Black box warning: reduced effectiveness in CYP2C19 poor metabolizers
GP 11b/111a Inhibitors prototype: Eptifibatide
Used in ACS/ other coronary interventions
MOA:
blocks GP IIb/ IIIa receptors (final step of aggregation)
ADR:
severe bleeding
Unfractionated Heparin
MOA:
inhibits factor Xa and thrombin
ADR:
bleeding
HIT
*antidote = protamine sulfate
BLACK BOX: spinal/ epidural bleeding = paralysis
Low-molecular-weight heparin: Enoxaparin
MOA:
mainly inhibits factor Xa
ADR
bleeding/ HIT
*Protamine sulfate is not as effective for reversal
* Rotate injection sites
BLACK BOX: spinal/ epidural bleeding = paralysis
Heparin-Induced Thrombocytopenia (HIT)
Immune reaction to heparin = increases blood clots
antibodies form against heparin
around 50% decrease of platelets
usually occurs 5-10 days after starting heparin
S/S:
new DVT/ PE
Vit K antagonist: Warfarin
MOA:
blocks vitamin K recycling —> decreases production of clotting factors
works on the extrinsic pathways
ADR:
bleeding/ hemorrhage
BLACK BOX: major/ fatal bleeding
*monitor INR (usually 2-3)
*maintain consistent vitamin K (leafy greens)
*antidote = vitamin K
Direct Oral Anticoagulants
factor Xa inhibitors
direct thrombin inhibitors
Factor Xa Inhibitors: apixaban
MOA:
blocks factor Xa —> decreases thrombin
*antidote: 4-factor PCC
Thrombin Inhibitors: dabigatran
MOA:
Blocks thrombin —> decreases fibrin
*antidote = idarcizumab
Thrombolytics (Fibrinolytics) Prototype
Prototype: alteplase
similar: Tenecteplase
Alteplase
Used for acute ischemic stroke, PE, or MI
MOA:
converts plasminogen —> dissolves existing clots
ADR:
severe bleeding
intracranial hemorrhage
*do not give to people who are stable